Bjørn Broby Glavind

Saving Hearts & Minds, COO @ Neurescue. Entrepreneur | Board Member | Venture Advisor

📍 Copenhagen, Capital Region, Denmark🔄 Updated September 2026💼 2 investments📅 6 years investing🗓 Last invested Aug 2025
VC🌍 Denmark
2
Total investments
2
Early stage
0
Mid stage
0
Late stage
6y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Aug 2025
Havn offers eco-friendly luxury homes nestled in nature in the Nordics, just a short commute away, with unique experiences for solo travellers, couples, and families. “Take a break from your busy life and immerse yourself in the natural world. Experience our eco-friendly nature homes and rediscover meaningful connections— with yourself, your loved ones, and the beauty around you.” -Your Havn Team Check out one of our beautiful cabins: airbnb.com/h/experiencefreyja
early stageHospitality
Board Member
Nov 2020
We develop and produce advanced health care solutions Our combined product offering of medical devices is designed to target various dermatology disorders. Our solutions range from killing bacteria without harming human cells and in the future to provide robotics-assisted debridements and collecting wound imagery and predict wound outcome on our own Electronic Medical Record (EMR) system. FlashHeal FlashHeal is a class II light-based medical device intended for managing dermatology disorders. The device was FDA cleared in Jan 2024. FlashClean FlashClean is a later iteration of FlashHeal and features a 6-axis robotic arm that enables it to perform automated debridements using laser. Development is ongoing. MIMR MIMR Optics is your go-to hand-held device for advanced imaging needs. Capture high-resolution standard images with exceptional clarity, precisely measure distances to your target area, and explore the detailed world of bioluminescence (fluorescence) imaging. Additionally, MIMR Optics offers accurate thermal imaging based on the heat emitted by the target area, making it a comprehensive tool for various applications. Development is ongoing. MIMR Insight, our cloud-based software, enables healthcare professionals to closely monitor the healing process by synchronizing and processing data collected by MIMR Optics and other devices with AI. MIMR Insight provides a comprehensive overview of the wound condition by detecting tissues or structures and identifying potentially harmful bacteria levels through autofluorescence imaging, measuring wound area and dimensions with precision, and capturing thermal images to assess the thermal intensity of the wound. Development is ongoing. About us We are a Danish company based in Copenhagen. We do everything in-house, all the way from development to production of our devices. Because of a lot of positive feedback, we are currently looking to enter the US market.
Experience · 7 entries
All (7)
Investments (2)
Founder (4)
Board (1)
2025
Investor
Aug 2025
Havn offers eco-friendly luxury homes nestled in nature in the Nordics, just a short commute away, with unique experiences for solo travellers, couples, and families. “Take a break from your busy life and immerse yourself in the natural world. Experience our eco-friendly nature homes and rediscover meaningful connections— with yourself, your loved ones, and the beauty around you.” -Your Havn Team Check out one of our beautiful cabins: airbnb.com/h/experiencefreyja
early stageHospitality
2020
Board Member
Nov 2020
We develop and produce advanced health care solutions Our combined product offering of medical devices is designed to target various dermatology disorders. Our solutions range from killing bacteria without harming human cells and in the future to provide robotics-assisted debridements and collecting wound imagery and predict wound outcome on our own Electronic Medical Record (EMR) system. FlashHeal FlashHeal is a class II light-based medical device intended for managing dermatology disorders. The device was FDA cleared in Jan 2024. FlashClean FlashClean is a later iteration of FlashHeal and features a 6-axis robotic arm that enables it to perform automated debridements using laser. Development is ongoing. MIMR MIMR Optics is your go-to hand-held device for advanced imaging needs. Capture high-resolution standard images with exceptional clarity, precisely measure distances to your target area, and explore the detailed world of bioluminescence (fluorescence) imaging. Additionally, MIMR Optics offers accurate thermal imaging based on the heat emitted by the target area, making it a comprehensive tool for various applications. Development is ongoing. MIMR Insight, our cloud-based software, enables healthcare professionals to closely monitor the healing process by synchronizing and processing data collected by MIMR Optics and other devices with AI. MIMR Insight provides a comprehensive overview of the wound condition by detecting tissues or structures and identifying potentially harmful bacteria levels through autofluorescence imaging, measuring wound area and dimensions with precision, and capturing thermal images to assess the thermal intensity of the wound. Development is ongoing. About us We are a Danish company based in Copenhagen. We do everything in-house, all the way from development to production of our devices. Because of a lot of positive feedback, we are currently looking to enter the US market.
2018
Co-Founder & Steering Member
Mar 2018
Making impact investment mainstream. The Nordic Impact Investing Network (NIIN) connects the venture ecosystem in the Nordics, driving action and capital flow to tackle the world’s largest problems. Welcome to a new era where impact investing is the status quo with the Nordics leading the way. To position the Nordic region as a leading example of impact investment there is a need for a trusted, connected and educated ecosystem. NIIN connects impact investors, activities and communities in the Nordics, creating transparency and opportunities for its members. Join the network http://nordicimpact.network
Co-Founder & Steering Member
Mar 2018
Making impact investment mainstream. The Nordic Impact Investing Network (NIIN) connects the venture ecosystem in the Nordics, driving action and capital flow to tackle the world’s largest problems. Welcome to a new era where impact investing is the status quo with the Nordics leading the way. To position the Nordic region as a leading example of impact investment there is a need for a trusted, connected and educated ecosystem. NIIN connects impact investors, activities and communities in the Nordics, creating transparency and opportunities for its members. Join the network http://nordicimpact.network
2016
COO & Associate Co-founder
Dec 2016
Neurescue develops cardiovascular devices to improve outcomes for emergency patients. Its flagship product, the NEURESCUE® device, an intelligent & fluoroscopy-free balloon catheter, is the first approved for the treatment of non-shockable cardiac arrest. By increasing blood flow to the brain and heart, the NEURESCUE device helps increase resuscitation rates. Every year, 81% of cardiac arrest patients present as non-shockable, making them ineligible for defibrillation. Today, only 4% of these patients survive. The NEURESCUE device directly addresses this urgent unmet need. The NEURESCUE device consists of a catheter and a handheld control unit. By temporarily inflating a soft balloon in the descending aorta, it redirects blood flow toward the heart and brain, supercharging circulation to the most critical organs during CPR. The intelligent, fluoroscopy-free device can boost central blood flow within one minute of deployment, thereby restoring the patient’s heartbeat in itself and buying time to bridge the patient to interventions such as a heart-lung-machine, percutaneous ventricular assist devices, and percutaneous coronary intervention. The device features automated inflation and sensor-guided feedback to facilitate a precise and safe procedure from start to finish. About Non-shockable Cardiac Arrest Non-shockable cardiac arrest cannot be treated with defibrillators. To survive a cardiac arrest, a patient must maintain blood flow to both the brain and the heart and achieve a return of spontaneous circulation (a regained heartbeat) or conversion to a shockable rhythm, either of which makes the patient eligible to be bridged to additional therapy.
Show all 7 entries ↓